Randomized IDE study met all primary and secondary safety and efficacy endpoints and demonstrated superior debris capture and significantly higher technical success versus the leading embolic ...
SANTA CRUZ, Calif., March 11, 2026 /PRNewswire/ -- Emboline, Inc., a privately held medical technology company focused on reducing stroke and ischemic damage during structural heart procedures such as ...
SANTA CRUZ, Calif., Oct. 23, 2025 /PRNewswire/ -- Emboline, Inc., a leading innovator in full-body embolic protection devices for transcatheter procedures, today announced completion of patient ...
PHOENIX, March 11, 2026 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity"), a leading international alternative asset manager, today announced the commitment of $20 million in growth ...
The Emboliner ® is the first device to provide complete brain and body protection from ischemic events such as stroke caused by embolic debris released into the bloodstream during transcatheter heart ...
AorticLab's FLOWer™ embolic protection device has received full clearance following the Unified Patent Court's clear dismissal of Emboline's infringement claims regarding European Patent EP 2129425, ...
SANTA CRUZ, Calif., Oct. 28, 2024 /PRNewswire/ -- Emboline, Inc., a privately held medical technology company based in Santa Cruz, CA, USA, today announced filing of a patent infringement lawsuit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results